The investigators will evaluate the efficacy of multi-strain probiotics in adults with diarrhea predominant irritable bowel syndrome.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
70
* B. longum BORI: 1 x 109 * B. bifidum BGN4: 1 x 109 * B. lactis AD011: 1 x 109 * B. infantis IBS007: 1 x 109 * Lactobacillus acidophilus AD031: 1 x 109 three times a day, within 10 minutes after meal, per oral with water
same taste, shape, dosage as experimental drug three times a day, within 10 minutes after meal, per oral with water
Seoul National University Hospital
Seoul, South Korea
RECRUITINGchange of Irritable bowel syndrome symptom severity score (IBS-SSS)
Severity and frequency of abdominal pain / abdominal bloating / bowel habitus / interfere degree of daily life
Time frame: after 8 weeks
Stool frequency and form
Stool frequency (greater than 3 bowel movements/day or less than 3 bowel movements/week) Stool form (lumpy / hard or loose / watery stool)
Time frame: after 4 weeks and 8 weeks
Symptom control of irritable bowel syndrome
Time frame: after 4 weeks and 8 weeks
Improvement of overall symptom in patient with irritable bowel syndrome
Time frame: after 4 weeks and 8 weeks
Assessment for quality of life related with irritable bowel syndrome
Time frame: after 4 weeks and 8 weeks
Assessment for patient satisfaction after administration completion
Time frame: after 4 weeks and 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.